Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study (Q34507237)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
scientific article

    Statements

    Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study (English)
    0 references
    0 references
    0 references
    0 references
    Olga De Santis
    Régine Audran
    Emilie Pothin
    Loane Warpelin-Decrausaz
    Laure Vallotton
    Camille Cochet
    Daniel Estoppey
    Viviane Steiner-Monard
    Sophie Lonchampt
    Anne-Christine Thierry
    Carole Mayor
    Robert T Bailer
    Olivier Tshiani Mbaya
    François Spertini
    22 December 2015

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit